Clinical and Translational Science (CTS) has been a fundamental and highly valued element of Mayo Clinic since its founding, and Mayo Clinic's mission ?to provide the best care to every patient every day through integrated clinical practice, education, and research? has always aligned well with the NCATS mission. Mayo Clinic is an integrated academic group practice with major sites in Minnesota, Arizona, and Florida; a large community Health System (MCHS) in Minnesota, Wisconsin, and Iowa; and an affiliated national ?Care Network? (MCCN). Thus, the Mayo Clinic Center for Clinical and Translational Science (CCaTS) is of national scope. MCHS and MCCN provide unique laboratories for late-stage dissemination and implementation research as well as for the conduct of high-priority clinical trials in community health care organizations. Mayo Clinic is also leading both a PCORI CDRN and a PPRN. These widespread connections, and programs that span the translational spectrum, position Mayo Clinic CCaTS to become a true ?hub? for CTS. The present application builds on key accomplishments over the previous 5 years in each of the major areas relevant to the NCATS mission. Mayo CCaTS has mature, innovative programs in workforce development for all members of CTS teams and is diversifying them through online and experiential learning. Incentivizing Team Science has always been part of the institutional culture at Mayo, and we are continuing to build on that strength. Given its role, particularly in Rochester, as a major local and regional provider of health care, community engagement has also been a priority for Mayo Clinic, and a range of methods for bidirectional engagement are proposed. Advances in informatics are also enabling us to connect with new and diverse patient populations. Thus, in light of our institutional traditions and accomplishments over the past 5 years, we believe we are uniquely positioned to accomplish our Specific Aims:
Aim 1. Train and maintain an outstanding multidisciplinary CTS workforce, including the entire spectrum of individuals involved in CTS;
Aim 2. Eliminate barriers to the work of translation by streamlining methods and processes, including improved and innovative informatics tools, completing the transformation of Mayo's clinical trial process, and accelerating the implementation of trial results and other discoveries to improve patient care;
Aim 3. Engage and incorporate a range of diverse stakeholders as active participants in CCaTS, both in leadership roles and in specific research projects, to improve the process of translation and the delivery of health care, promoting community engagement in research among our Mayo workforce and engaging our local and national communities using both traditional and innovative approaches;
and Aim 4. Expand, strengthen, and streamline our regional and national collaborations in all aspects of CTS and education, connecting with our regional and national partners, as well as with the CTSA Consortium, to achieve the ultimate goal of NCATS to improve patient care and human health.

Public Health Relevance

The Mayo Clinic Center for Clinical and Translational Science (CCaTS) aims to catalyze the translation of research findings into clinically useful treatments and methods. Its overall goals are to facilitate the development of new therapies and their implementation in clinical practice; to train the next generation of clinical and translational physicians and scientists; to engage communities to fully participate in the translational research process; and to partner with regional and national networks to ultimately improve patient care and human health.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR002377-02S1
Application #
9744067
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Davis Nagel, Joan
Project Start
2017-09-18
Project End
2022-06-30
Budget Start
2018-08-01
Budget End
2019-06-30
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Master, Zubin; Martinson, Brian C; Resnik, David B (2018) Expanding the Scope of Research Ethics Consultation Services in Safeguarding Research Integrity: Moving Beyond the Ethics of Human Subjects Research. Am J Bioeth 18:55-57
Yu, Jia; Qin, Bo; Moyer, Ann M et al. (2018) DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine. J Clin Invest 128:2376-2388
Reddy, Yogesh N V; Carter, Rickey E; Obokata, Masaru et al. (2018) A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction. Circulation 138:861-870
Sharp, Richard R; Allyse, Megan A (2018) When to Avoid Giving Advice on the Ethical Conduct of Research. Am J Bioeth 18:94-95
Master, Zubin (2018) Procedures to Promote Ethical Open Access Publishing: A Comment to Shaw and Elger. Account Res 25:417-418
Mangold, Kara; Kunze, Katie L; Quinonez, Michelle M et al. (2018) Learning Style Preferences of Practicing Nurses. J Nurses Prof Dev 34:212-218
Huang, Ming; ElTayeby, Omar; Zolnoori, Maryam et al. (2018) Public Opinions Toward Diseases: Infodemiological Study on News Media Data. J Med Internet Res 20:e10047
Xie, Jiang; Sert Kuniyoshi, Fatima H; Covassin, Naima et al. (2018) Excessive Daytime Sleepiness Independently Predicts Increased Cardiovascular Risk After Myocardial Infarction. J Am Heart Assoc 7:
Vargas, Eric J; Pesta, Carl M; Bali, Ahmad et al. (2018) Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-World Population. Clin Gastroenterol Hepatol 16:1073-1080.e1
Halawi, H; Vijayvargiya, P; Busciglio, I et al. (2018) Effects of naloxegol on whole gut transit in opioid-naïve healthy subjects receiving codeine: A randomized, controlled trial. Neurogastroenterol Motil 30:e13298

Showing the most recent 10 out of 19 publications